REGISTRY SNAPSHOT: Iranian Registry of Clinical Trials (IRCT)

by Staff writer,
Posted on 4/2/2019

Knowing which countries to submit clinical trial results summaries to is the easy part. What becomes difficult is learning the intricacies and transparency requirements of every clinical trial registry globally, including the Iranian Registry of Clinical Trials (IRCT). Here is an overview of this registry:

Iranian Registry of Clinical Trials (IRCT)

The Iranian Registry of Clinical Trials (IRCT) is hosted by the IUMS (pictured)

Registry name: Iranian Registry of Clinical Trials (IRCT)

Country: Iran

Year established: 2008

Points of interest:

  • The IRCT is a primary registry in the WHO Network, with help from the Ministry of Health and Medical Education (MOHME)
  • The registry is hosted by the Iran University of Medical Sciences (IUMS)
  • One main objective of the IRCT is to implement the International Committee of Medical Journal Editors initiative for mandatory registration of trials before the enrollment of the first patient
  • A committee of distinguished researchers and Iran’s top medical journal editors oversee the registry’s activities
  • The registry is bilingual – available in Persian and English; however, researchers from other countries can register their trials solely in English
  • Trials conducted and published in Iran must be registered in Persian, in the Iranian registry
  • As of March 2019, 20,197 clinical trials have been registered with the IRCT, a large increase from 182 registered clinical trials in 2009
  • The IRCT organizes short training courses and workshops on issues related to clinical trials and their registration

Related transparency research/articles:

TrialAssure® Registry can automate the disclosure of clinical trial results for the Iranian Registry of Clinical Trials (IRCT). For questions or a free demo, fill out this form.

Share: